​

Funding Round

Series A - Nalagenetics

Series A - Nalagenetics

Investment Firm

Overview

Nalagenetics is a biotechnology company that provides genetic testing services.

Announced Date

Mar 25, 2022

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Vulcan Capital

Vulcan Capital

Vulcan Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

3

Investor Name
Participant InvestorThe Agency for Science, Technology and Research
Participant InvestorIntegra Partners
Participant InvestorVulcan Capital

Round Details and Background

Nalagenetics raised $12600000 on 2022-03-25 in Series A

Nalagenetics is a biotechnology company that provides genetic testing services.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 01, 2022
Non Equity Assistance - Nalagenetics
1-undefined
Jun 26, 2023
Non Equity Assistance - Nalagenetics
1-undefined
Feb 02, 2022
Non Equity Assistance - Nalagenetics
1-undefined
May 01, 2024
Grant - Nalagenetics
1-undefined

Recent Activity

There is no recent news or activity for this profile.